Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Recombination and flavivirus vaccines: a commentary.

Literature DB >> 15811640

Recombination and flavivirus vaccines: a commentary.

Thomas P Monath¹, Niranjan Kanesa-Thasan, Farshad Guirakhoo, Konstantin Pugachev, Jeffrey Almond, Jean Lang, Marie-Jose Quentin-Millet, Alan D T Barrett, Margo A Brinton, Martin S Cetron, Rachel S Barwick, Thomas J Chambers, Scott B Halstead, John T Roehrig, Richard M Kinney, Rebecca Rico-Hesse, James H Strauss.

Abstract

Mesh：

Substances：
Viral Vaccines

Year: 2005 PMID： 15811640 DOI： 10.1016/j.vaccine.2004.11.069

Source DB: PubMed Journal: Vaccine ISSN： 0264-410X Impact factor: 3.641

Keyword Cloud
Cited

× No keyword cloud information.

13 in total

Review 1. Live virus vaccines based on a yellow fever vaccine backbone: standardized template with key considerations for a risk/benefit assessment.

Authors: Thomas P Monath; Stephen J Seligman; James S Robertson; Bruno Guy; Edward B Hayes; Richard C Condit; Jean Louis Excler; Lisa Marie Mac; Baevin Carbery; Robert T Chen
Journal: Vaccine Date: 2014-10-27 Impact factor: 3.641

2. West Nile virus (WNV) genome RNAs with up to three adjacent mutations that disrupt long distance 5'-3' cyclization sequence basepairs are viable.

Authors: Mausumi Basu; Margo A Brinton
Journal: Virology Date: 2011-02-02 Impact factor: 3.616

3. PCP consensus sequences of flaviviruses: correlating variance with vector competence and disease phenotype.

Authors: Petr Danecek; Wenzhe Lu; Catherine H Schein
Journal: J Mol Biol Date: 2009-12-04 Impact factor: 5.469

4. A trans-complementing recombination trap demonstrates a low propensity of flaviviruses for intermolecular recombination.

Authors: Christian Taucher; Angelika Berger; Christian W Mandl
Journal: J Virol Date: 2010-01 Impact factor: 5.103

5. Dengue virus type 3 vaccine candidates generated by introduction of deletions in the 3' untranslated region (3'-UTR) or by exchange of the DENV-3 3'-UTR with that of DENV-4.

Authors: Joseph E Blaney; Neeraj S Sathe; Laura Goddard; Christopher T Hanson; Tammy A Romero; Kathryn A Hanley; Brian R Murphy; Stephen S Whitehead
Journal: Vaccine Date: 2007-12-26 Impact factor: 3.641

Recombination and flavivirus vaccines: a commentary.

Review 1. Live virus vaccines based on a yellow fever vaccine backbone: standardized template with key considerations for a risk/benefit assessment.

2. West Nile virus (WNV) genome RNAs with up to three adjacent mutations that disrupt long distance 5'-3' cyclization sequence basepairs are viable.

3. PCP consensus sequences of flaviviruses: correlating variance with vector competence and disease phenotype.

4. A trans-complementing recombination trap demonstrates a low propensity of flaviviruses for intermolecular recombination.

5. Dengue virus type 3 vaccine candidates generated by introduction of deletions in the 3' untranslated region (3'-UTR) or by exchange of the DENV-3 3'-UTR with that of DENV-4.

6. Stability of yellow fever virus under recombinatory pressure as compared with chikungunya virus.

7. Coinfection rates in Φ6 bacteriophage are enhanced by virus-induced changes in host cells.

8. Multiple recombinant dengue type 1 viruses in an isolate from a dengue patient.

9. Multiple recombinants in two dengue virus, serotype-2 isolates from patients from Oaxaca, Mexico.

Review 10. Dengue virus virulence and transmission determinants.